WE
ALT icon

Wealth Effects’s Altimmune ALT Stock Holding History

Wealth Effects’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Sell
122,650
-9,300
-7% -$27.8K 0.1% 163
2026
Q1 		$406K Buy
131,950
+20,200
+18% +$85.8K 0.14% 130
2025
Q4 		$403K Buy
111,750
+51,900
+87% +$226K 0.13% 125
2025
Q3 		$226K Buy
59,850
+28,100
+89% +$108K 0.07% 190
2025
Q2 		$123K Buy
31,750
+900
+3% +$4.87K 0.05% 197
2025
Q1 		$154K Sell
30,850
-2,000
-6% -$12.7K 0.06% 188
2024
Q4 		$237K Sell
32,850
-2,200
-6% -$16.8K 0.08% 184
2024
Q3 		$215K Sell
35,050
-2,500
-7% -$16.9K 0.08% 187
2024
Q2 		$250K Buy
37,550
+22,850
+155% +$169K 0.09% 165
2024
Q1 		$150K Buy
+14,700
New +$150K 0.06% 205

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Effects's ALT Position: Q2 2026 in Review

Wealth Effects reduced its Altimmune (ALT) stake by 7% in Q2 2026, selling an estimated $27.8K and leaving 122,650 shares worth $373K. The position accounts for 0.1% of the portfolio, ranked #163.

Wealth Effects first reported a position in ALT in Q1 2024 and has held it in 10 quarters since. The position peaked at $406K in Q1 2026. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Wealth Effects held 122,650 shares of Altimmune worth $373K as of Q2 2026.
  • Wealth Effects sold 9,300 Altimmune shares in Q2 2026, an estimated $27.8K.
  • Altimmune made up 0.1% of Wealth Effects's portfolio in Q2 2026, its #163 holding.
  • Wealth Effects first reported a position in Altimmune in Q1 2024 and has held it in 10 quarters since.
  • Wealth Effects's Altimmune position peaked at $406K in Q1 2026.
  • 211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.